This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Rare cases with recurrent reversible cerebral vasoconstriction syndrome (RCVS) have been published. The authors analyzed the recurrence risk of RCVS in a large Taiwanese cohort; 210 patients with a definite RCVS were followed up during a mean period of about 3 ± 2 years, with slightly less than 20% of cases lost to follow-up, leaving 168 patients for the final analysis.1
Footnotes
Study funding: No targeted funding reported.
Disclosure: A. Ducros serves as associate editor of Cephalalgia, and of Headache, as member of the editorial advisory board of The Journal of Headache and Pain, received travel expenses and honoraria for an advisory board from Amgen, received travel and meeting expenses from Almirall, received travel expenses and/or honoraria for lectures or educational activities not funded by industry, received honoraria for speaking engagements from Bausch & Lomb, receives institutional support from the French government (Contrat d'Initiation à la Recherche Clinique, Programme Hospitalier de Recherche Clinique) for clinical research. Go to Neurology.org for full disclosures.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
Recurrence of reversible cerebral vasoconstriction syndrome
Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients
Early Risk of Readmission Following Hospitalization for Reversible Cerebral Vasoconstriction Syndrome